A Baltimore biotech-wellness brand · $120K → $540K MRR.

This archetype is a slice of Baltimore biotech-DTC we ship into reliably: a wellness supplement or science-led skincare operator spinning out of the Hopkins corridor. The founder's credibility is rooted in real R-and-D experience. The buyer reads ingredient panels before marketing copy.

Pre-engagement, the brand sat at $120K MRR on a Shopify Basic setup. Product detail pages spoke to general-DTC buyers, not evidence-first wellness buyers. No FDA-aware Supplement Facts panels. No real subscription mechanics on dose-cadence SKUs. And a Klaviyo program running three flows on default templates.

Three structural problems compounded the growth ceiling. First, the product detail pages buried the brand's R-and-D credibility: third-party studies, ingredient sourcing, dose-rationale. Wellness buyers expect that evidence up front. Conversion sat at 1.4 percent against an industry baseline closer to 2.8 to 3.5 percent.

Second, dose-cadence SKUs, the daily-supplement line buyers consume monthly, had no subscription product to attach to. That left roughly 40 percent of plausible repeat revenue on the table. Third, Klaviyo could not tell the dose-cadence cohort from one-time buyers, so messaging cadences hurt retention rather than helped it.

Workstream 1 · Shopify Plus migration with FDA-aware product surfaces. We moved the store from Shopify Basic to Plus and rebuilt the product detail templates around evidence. Supplement Facts panels render from Shopify metafields, not copy-paste images. Dose-rationale callouts and third-party study citations sit inline. Conversion lifted from 1.4 percent to 2.6 percent across 90 days post-launch.

Workstream 2 · Subscription on dose-cadence SKUs. We integrated Recharge for the daily-supplement line, with skip, pause, and swap mechanics tied to dose-cadence intervals. Subscription attach reached 36 percent of repeat customers within 5 months. M12 cohort retention held at 68 percent.

Workstream 3 · Klaviyo flows + dose-cadence segmentation. The welcome series now keys off the first product purchased. Browse abandonment, cart abandonment, post-purchase, win-back, and dose-replenishment flows are segmented across three cohorts: dose-cadence, one-time buyer, and lapsed subscriber. Email revenue share moved from 8 percent of total to 29 percent over 6 months.

Workstream 4 · Bundle + dose-package merchandising. We built bundle SKUs that group dose-cadence essentials with adjacent products, like vitamin-D plus magnesium plus B-complex. AOV moved from $74 to $112 across 12 months. Bundle attach rate reached 22 percent.

Workstream 5 · Evidence-citation content surfaces. We built a /research index that links every product to the third-party studies behind its dose claims. Each citation carries MedicalStudy schema markup. That index became one of the top three highest-converting pages on the site.

If your brand fits this pattern, the playbook transfers. The pattern: a Baltimore biotech-DTC or wellness supplement operator in the $80K to $250K MRR range, with credible R-and-D positioning but product detail pages built for general DTC rather than evidence-first wellness buyers. It is one of our most-shipped engagement shapes for the Mid-Atlantic.

The 12-week timeline holds steady. Workstreams compress or expand in proportion. Metrics typically land within plus or minus 20 percent of the archetype above.

Five capabilities transfer directly to a comparable Baltimore engagement.

1. Shopify Plus migration with FDA-aware product detail surfaces. Structured Supplement Facts panels rendered from metafields.
2. Subscription on dose-cadence SKUs. Converts the top 30 to 40 percent of repeat customers into a high-LTV recurring base.
3. Klaviyo flow architecture. Earns 25 to 30 percent of total revenue from email through dose-cadence segmentation.
4. Bundle and dose-package merchandising. Lifts AOV by 30 to 50 percent.
5. An evidence-citation content surface. Links every dose claim to third-party studies inline.

Every Baltimore engagement starts with a 30-minute discovery call. Scope, timeline, and budget come back in writing within 48 hours. Eastern Time, same-day response Monday to Friday 9 to 6.